O'Neill C - Search Results

1

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.

Frank S, Testa C, Edmondson MC, Goldstein J, Kayson E, Leavitt BR, Oakes D, O'Neill C, Vaughan C, Whaley J, Gross N, Gordon MF, Savola JM; Huntington Study Group/ARC-HD Investigators and Coordinators. Frank S, et al. CNS Drugs. 2022 Nov;36(11):1207-1216. doi: 10.1007/s40263-022-00956-8. Epub 2022 Oct 15. CNS Drugs. 2022. PMID: 36242718 Free PMC article. Clinical Trial.

2

Quality of life consequences of chemotherapy-induced emesis.

Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT. Lindley CM, et al. Qual Life Res. 1992 Oct;1(5):331-40. doi: 10.1007/BF00434947. Qual Life Res. 1992. PMID: 1299465

3

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

4

Suspected acute interstitial nephritis induced by piperacillin-tazobactam.

Pill MW, O'Neill CV, Chapman MM, Singh AK. Pill MW, et al. Pharmacotherapy. 1997 Jan-Feb;17(1):166-9. Pharmacotherapy. 1997. PMID: 9017778

5

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

6

Geographic disparities in thyroid cancer staging at presentation: Insights from an Australian context.

Yang ZM, Tong CW, Bhimani N, O'Neill CJ, Lai CSL, Serpell JW, Glover AR. Yang ZM, et al. Among authors: o neill cj. World J Surg. 2024 May 11. doi: 10.1002/wjs.12211. Online ahead of print. World J Surg. 2024. PMID: 38733313

7

Facing up to Problem Gambling: Tracing the Emergence of Facial Recognition Technology as a means of Enforcing Voluntary Self-Exclusion.

Selwyn N, Smith G, Andrejevic M, Gu X, O'Neill C. Selwyn N, et al. Among authors: o neill c. J Gambl Stud. 2024 May 9. doi: 10.1007/s10899-024-10308-4. Online ahead of print. J Gambl Stud. 2024. PMID: 38724824

8

Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy.

Toal M, Fergie R, Quinn M, Hill C, O'Neill C, Maxwell AP. Toal M, et al. Among authors: o neill c. Syst Rev. 2024 May 4;13(1):122. doi: 10.1186/s13643-024-02543-y. Syst Rev. 2024. PMID: 38704598 Free PMC article.

9

A survey of multiple candidate probiotic bacteria reveals specificity in the ability to modify the effects of key wound pathogens.

Alhubail M, McBain AJ, O'Neill CA. Alhubail M, et al. Among authors: o neill ca. Microbiol Spectr. 2024 May 3:e0034724. doi: 10.1128/spectrum.00347-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38700333 Free article.

10

T cell characteristics impact response and resistance to T cell-redirecting bispecific antibodies in multiple myeloma.

Verkleij CPM, O'Neill CA, Broekmans MEC, Frerichs KA, Bruins WSC, Duetz C, Kruyswijk S, Baglio SR, Skerget S, Montes de Oca R, Zweegman S, Verona RI, Mutis T, van de Donk NWCJ. Verkleij CPM, et al. Among authors: o neill ca. Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-23-3333. Online ahead of print. Clin Cancer Res. 2024. PMID: 38687588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,345 results

Search Page